About me
- Research Assistant Professor of Medicine (Translational Medicine and Human Genetics)
My Locations
Qualifications and experience
- ACCP, National
- American Heart Association, National
- American Society for Clinical Pharmacology and Therapeutics (ASCPT), National
- Clinical Implementation Consortium (CPIC), National
- Pharmacogenomics Global Research Network, International
Treatments and Conditions
My research
Tuteja S, O'Brien WJ, Ferraro JP, Damrauer SM, Itani KMF, Voight BF, Teerlink CC, Lynch JA, DuVall SL, Strebel T, Kim MJ, Wilson MA, Barrett TW; Million Veteran Program. Drug-Gene Interactions and Clinical Outcomes After Vascular Surgery in the Million Veteran Program , JAMA Surg, 160: 2025,804-813
Tuteja S, Cayabyab MAS, Hoffecker G, Varughese LA, de Dieu Ndayishimiye J, Wittner VA, Wang X, Hatch R, Capozzi D, Harr M, Santani A, Hakonarson H, Watson D, Gabriel P, Doucette A, Massa R, Damjanov N, Reddy N, Oyer R, Teitelbaum UR. Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial , JCO Precis Oncol: 2025,e2500086. doi: 10.1200/PO-25-00086
Yang G, Alarcon C, Chanfreau C, Lee NH, Friedman P, Nutescu E, Tuck M, O'Brien T, Gong L, Klein TE, Chang KM, Tsao PS, Meltzer DO, Lynch JA; Million Veteran Program; Tuteja S, Perera MA. Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans , Clin Pharmacol Ther, 117(5): 2025,1313-1324
Chanfreau-Coffinier C, Friede KA, Plomondon ME, Lee KM, Lu Z, Dinatale T, DuVall SL, Vassy JL, Waldo SW, Cleator JH, Maddox TM, Rader DJ, Assimes TL, Damrauer SM, Tsao PS, Chang KM, Voora D, Lynch JA, Giri J; VA Million Veteran Program; Tuteja S. CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program , Clin Pharmacol Ther, 118(4): 2025,876-884
Ho TT, Smith DM, Aquilante CL, Cicali EJ, El Rouby N, Hertz DL, Imanirad I, Patel JN, Scott SA, Swain SM, Tuteja S, Hicks JK; Pharmacogenomics Global Research Network Publication Committee. A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice , Clin Pharmacol Ther, 117(5): 2025,1194-1208
Stevenson JM, Smith DM, Tuteja S, Patel JN; Pharmacogenomics Global Research Network (PGRN) Publications Committee. Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test , Clin Pharmacol Ther, 118(3): 2025,561-566
Hoffecker G, Mulugeta-Gordon L, Wittner V, Wang X, Gysler S, Deagostino-Kelly M, Tuteja S. Feasibility of pharmacogenetic-guided selection of postoperative analgesics in gynecologic surgery patients: a prospective, randomized, pilot study , Pharmacogenet Genomics, 35: 2025,183-191
Pereira NL, Cresci S, Angiolillo DJ, Batchelor W, Capers Q 4th, Cavallari LH, Leifer D, Luzum JA, Roden DM, Stellos K, Turrise SL, Tuteja S; American Heart Association Professional/Public Education and Publications Committee of the Council on Genomic and Precision Medicine; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Stroke Council. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association , Circulation, 150: 2024,e129-e150
Oni-Orisan A, Tuteja S, Hoffecker G, Smith DM, Castrichini M, Crews KR, Murphy WA, Nguyen NHK, Huang Y, Lteif C, Friede KA, Tantisira K, Aminkeng F, Voora D, Cavallari LH, Whirl-Carrillo M, Duarte JD, Luzum JA; Pharmacogenomics Global Research Network (PGRN) Publications Committee. An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers , Clin Pharmacol Ther, 114(2): 2023,275-287
Hoffecker G, Varughese LA, Bleznuck J, Landgraf J, Wollack C, Chen J, Ritchie MD, Nathanson KL, Tuteja S Customizing the electronic health record for delivery of pharmacogenetics. , Genetics in Medicine Open: 2023